Evidence map›Paper›PMID 28609433›Full record

ArticleBritish journal of cancer2017

Prioritising action on occupational carcinogens in Europe: a socioeconomic and health impact assessment.

J W Cherrie, S Hutchings, M Gorman Ng, R Mistry, C Corden, J Lamb, A Sánchez Jiménez, A Shafrir, M Sobey, M van Tongeren and 1 more

Abstract read
In one paragraph

Article in British journal of cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Assessing the Knowledge of Environmental Risk Factors for Cancer among the UAE Population: A Pilot Study.International journal of environmental research and public health · 2020
    Article
  12. Article
  13. Article
  14. Current and new challenges in occupational lung diseases.European respiratory review : an official journal of the European Respiratory Society · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

J W CherrieInstitute of Occupational Medicine, Research Avenue North, Edinburgh EH14 4AP, UK.
S HutchingsDepartment of Epidemiology and Biostatistics, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
M Gorman NgInstitute of Occupational Medicine, Research Avenue North, Edinburgh EH14 4AP, UK.
R MistryAmec Foster Wheeler Environment &Infrastructure UK Limited, 12th Floor, 25 Canada Square, London E14 5LQ, UK.
C CordenAmec Foster Wheeler Environment &Infrastructure UK Limited, 12th Floor, 25 Canada Square, London E14 5LQ, UK.
J LambInstitute of Occupational Medicine, Research Avenue North, Edinburgh EH14 4AP, UK.
A Sánchez JiménezInstitute of Occupational Medicine, Research Avenue North, Edinburgh EH14 4AP, UK.
A ShafrirInstitute of Occupational Medicine, Research Avenue North, Edinburgh EH14 4AP, UK.
M SobeyAmec Foster Wheeler Environment &Infrastructure UK Limited, 12th Floor, 25 Canada Square, London E14 5LQ, UK.
M van TongerenInstitute of Occupational Medicine, Research Avenue North, Edinburgh EH14 4AP, UK.
L RushtonDepartment of Epidemiology and Biostatistics, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWork-related cancer is an important public health issue with a large financial impact on society. The key European legislative instrument is the Carcinogens and Mutagens Directive (2004/37/EC). In preparation for updating the Directive, the European Commission commissioned a study to provide a socioeconomic, health and environmental impact assessment.

methodsThe evaluation was undertaken for 25 preselected hazardous substances or mixtures. Estimates were made of the number of cases of cancer attributable to workplace exposure, both currently and in the future, with and without any regulatory interventions, and these data were used to estimate the financial health costs and benefits.

resultsIt was estimated that if no action is taken there will be >700 000 attributable cancer deaths over the next 60 years for the substances assessed. However, there are only seven substances where the data suggest a clear benefit in terms of avoided cancer cases from introducing a binding limit at the levels considered. Overall, the costs of the proposed interventions were very high (up to [euro ]34 000 million) and the associated monetised health benefits were mostly less than the compliance costs.

conclusionsThe strongest cases for the introduction of a limit value are for: respirable crystalline silica, hexavalent chromium, and hardwood dust.

Indexed as

CarcinogensChromiumDustEuropeHealth Care CostsHealth Impact AssessmentHumansNeoplasmsOccupational ExposureSilicon DioxideCarcinogensChromiumchromium hexavalent ionDustSilicon Dioxide

Identifiers

PMID28609433
PMCPMC5520511

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.